WA-AMAZON.COM
Amazon (NASDAQ: AMZN) today announced the company’s 65th and 66th renewable energy projects. Amazon’s newest renewable energy project in the EU will be located in Cork, Ireland, and will be the second Amazon Wind Farm in the Republic of Ireland. Once complete, the new Amazon Wind Farm will provide 23.2 megawatts (MW) of renewable capacity, with expected generation of 68,000 megawatt hours (MWh) of clean energy annually. Amazon’s newest renewable energy project in the U.S. will be located in Pittsylvania County, Virginia, and will be the seventh Amazon Solar Farm in the Commonwealth of Virginia. Once complete, the new Amazon Solar Farm will provide 45 megawatts (MW) of renewable capacity and is expected to generate 100,000 megawatt hours (MWh) of clean energy annually. Both projects are expected to begin producing clean energy in 2020 and will supply clean energy to the company’s Amazon Web Services datacenters, which power Amazon and millions of AWS customers globally.
Additionally, Amazon’s investments in renewable energy were recently recognized in the Solar Energy Industries Association’s (SEIA) 2018 Solar Means Business Report , which ranked Amazon #1 in the U.S. for amount of corporate on-site solar installed in 2018, and #2 for total amount of solar installed to date. Amazon’s solar projects in the U.S. have offset the CO2 equivalent of more than 200 million miles of truck deliveries. Globally, Amazon has 66 renewable energy projects – including 51 solar rooftops – that are expected to generate 1,342 MW of renewable capacity and deliver more than 3.9 million MWh of clean energy annually.
“Playing a significant role in helping to reduce the sources of human-induced climate change is an important commitment for Amazon,” said Kara Hurst, Director of Sustainability, Amazon. “Major investments in renewable energy are a critical step to address our carbon footprint globally. We will continue to invest in these projects, and look forward to additional investments this year and beyond.”
“Under the Climate Action Plan, we are committing that 70 percent of Ireland’s electricity will come from renewable sources by 2030. Industry leadership is key to helping us reach this target,” said Richard Bruton, Ireland’s Minister for Communications, Climate Action and Environment. “This project is another example of AWS’s commitment to renewable projects in Ireland, adding clean energy to the grid, and supporting Ireland’s climate commitments. Construction will begin on this project this year and will start contributing to Ireland’s renewable energy capacity by 2020. We look forward to continuing to work with AWS as we strive to make Ireland a leader in the renewable energy space.”
“I applaud Amazon for their continued investment in clean and renewable energy projects in the Commonwealth of Virginia,” said Virginia Senator Mark R. Warner. “This solar energy project in Pittsylvania County will lead to a cleaner environment and more jobs in the community.”
“It’s wonderful to see the announcement of these new projects, which will help bring more renewable energy to the Commonwealth of Virginia where Amazon has already helped bring significant solar energy projects online,” said Virginia Governor Ralph Northam. “Amazon’s new solar farm in Virginia will create jobs and economic development in rural Virginia, and will continue to build upon our role as a leading state for renewable energy in the U.S.”
Beyond investments in wind and solar, Amazon has a long history of commitment to sustainability through innovative programs such as Shipment Zero , Frustration-Free Packaging, Ships in Own Container, investments in the circular economy with the Closed Loop Fund, and numerous other initiatives happening every day by teams across Amazon. Amazon has also implemented the District Energy Project that uses recycled energy to heat and cool more than 3 million square feet of office space. For more information on Amazon’s sustainability initiatives, visit www.amazon.com/sustainability .
About Amazon
Amazon is guided by four principles: customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. Customer reviews, 1-Click shopping, personalized recommendations, Prime, Fulfillment by Amazon, AWS, Kindle Direct Publishing, Kindle, Fire tablets, Fire TV, Amazon Echo, and Alexa are some of the products and services pioneered by Amazon. For more information, visit amazon.com/about and follow @AmazonNews .
About Amazon Web Services
For 13 years, Amazon Web Services has been the world’s most comprehensive and broadly adopted cloud platform. AWS offers over 165 fully featured services for compute, storage, databases, networking, analytics, robotics, machine learning and artificial intelligence (AI), Internet of Things (IoT), mobile, security, hybrid, virtual and augmented reality (VR and AR), media, and application development, deployment, and management from 66 Availability Zones (AZs) within 21 geographic regions, spanning the U.S., Australia, Brazil, Canada, China, France, Germany, Hong Kong Special Administrative Region, India, Ireland, Japan, Korea, Singapore, Sweden, and the UK. Millions of customers—including the fastest-growing startups, largest enterprises, and leading government agencies—trust AWS to power their infrastructure, become more agile, and lower costs. To learn more about AWS, visit aws.amazon.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20190801005260/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom